Explore 3 Stock Ideas & Industry Insights Download Free Report

small-cap

One NYSE- Listed Insurance Stock at Decent Technical Levels – Lemonade Inc

Apr 23, 2025 | Team Kalkine
One NYSE- Listed Insurance Stock at Decent Technical Levels – Lemonade Inc
Image source: Shutterstock

  • LMND:NYSE
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (US$)

Lemonade Inc

Lemonade, Inc. (NYSE: LMND) is a technology-driven insurance company founded in 2015, headquartered in New York City, with a mission to transform the insurance industry through artificial intelligence (AI) and behavioral economics. The Company offers a range of insurance products, including renters, homeowners, car, pet, and life insurance, primarily targeting millennials and younger demographics who value digital-first, transparent, and socially responsible services. Lemonade operates as a licensed insurance carrier in the United States and Europe, leveraging its proprietary technology platform to streamline the customer experience, from instant policy issuance to claims processing, often settling claims in seconds using AI-powered chatbots and automation.

Recent Business and Financial Updates

  • Exceptional Financial Performance in Q4 2024: Lemonade, Inc. (NYSE: LMND) delivered an outstanding fourth quarter in 2024, marking its strongest performance to date with significant financial achievements. The Company reported an In Force Premium (IFP) of USD944 million, reflecting a 26% year-over-year increase and marking its fifth consecutive quarter of accelerating growth, while revenue surged by 29% to USD148.8 million. Gross profit soared by 90% to USD64 million, achieving a margin expansion of 14 points to 43%, and the full-year gross profit nearly doubled to USD167 million, up 98% from 2023. The gross loss ratio improved to 63% in Q4, the best ever recorded by Lemonade, with the trailing twelve-month (TTM) gross loss ratio at 73%, aligning with the target range and showing a 12-point improvement year-over-year. Adjusted EBITDA loss narrowed by 18% to USD24 million, and for the first time, Adjusted EBITDA excluding growth spend was positive, while the quarter generated USD27 million in Adjusted Free Cash Flow (Adj. FCF), contributing to a full-year positive Adj. FCF of USD48 million.
  • Consistency and Predictability in 2024 Results: Lemonade’s 2024 financial performance underscored the reliability and predictability of its operating model, successfully meeting its initial guidance despite macroeconomic challenges such as elevated inflation and a highly active catastrophe season. The Company had forecasted an IFP range of USD938 to USD942 million and an Adjusted EBITDA loss of USD160 to USD155 million in February 2024, ultimately achieving USD944 million in IFP and an Adjusted EBITDA loss of USD150 million, reflecting a 13% improvement year-over-year. This precision in forecasting and execution highlights Lemonade’s resilience and strategic focus, delivering 26% IFP growth and sustained financial stability amidst industry headwinds, positioning it favorably for future scalability.
  • Key Drivers of Financial Success: The primary drivers of Lemonade’s 2024 performance were accelerating growth, underwriting excellence, and disciplined expense management, all underpinned by its proprietary AI-driven technology. Growth investments more than doubled to USD122 million from USD55 million in 2023, fueled by the Synthetic Agents program launched in July 2023, maintaining an LTV/CAC ratio above 3:1 and a triple-digit CAC IRR, resulting in five consecutive quarters of IFP growth acceleration. Underwriting precision, powered by the LTV model, achieved a TTM gross loss ratio within the target range, supported by regulatory rate approvals ensuring rate adequacy across most of the portfolio. Expense management remained disciplined, with operating expenses excluding growth spend rising only 2% to USD332 million, despite 26% topline growth, demonstrating significant operating leverage and a clear path to profitability.
  • Pet Insurance: A Model of Operational Excellence: Lemonade’s pet insurance segment exemplified the efficacy of its business model, achieving USD283 million in IFP by the end of 2024, a 57% increase from 2023, just four years after its launch. The segment recorded a gross loss ratio of 69%, meeting target levels, driven by AI-powered pricing models that enhanced underwriting granularity and improved conversion rates while lowering new business loss ratios. Operational efficiencies were notable, with the cost per claim dropping to a historic low of USD19, enabled by AI automations such as medical records review, which facilitated near-instant claims decisions. Operating in a rapidly growing market with a 26% multi-year CAGR and only 4% penetration, Lemonade’s pet insurance business is poised for continued expansion and efficiency gains.
  • Response to California Wildfires and Customer Commitment: The January 2025 California wildfires posed a significant challenge, with Lemonade estimating a Q1 2025 impact of USD45 million in gross losses and a USD20 million hit to Adjusted EBITDA. However, the Company’s diversified portfolio across home, renters, pet, and car insurance, along with proactive catastrophe exposure management, mitigated the potential impact, which could have been five times greater without these measures. Lemonade’s response was exemplary, leveraging AI and aerial imagery to settle hundreds of claims within an hour of submission, even amidst active fires and evacuations, earning a customer satisfaction score of 4.98 out of 5 and a Net Promoter Score of 91, reflecting its unwavering commitment to supporting customers during crises.
  • Strategic Growth Initiatives and 2025 Outlook: Lemonade extended its Synthetic Agents financing partnership with General Catalyst through December 2026, securing an additional USD200 million to fund growth investments, with a net outstanding balance of USD83 million at year-end 2024, having fully repaid borrowings from its first three cohorts. For 2025, the Company projects continued IFP growth of 28%, reaching USD1,203 to USD1,208 million, and revenue of USD655 to USD657 million, while anticipating an Adjusted EBITDA loss of USD140 to USD135 million, reflecting a 40% increase in growth spend and the wildfire impact. Lemonade expects to maintain positive Adj. FCF for the second consecutive year and remains on track to achieve positive Adj. EBITDA by the end of 2026, supported by its strategy of sustained growth, loss ratio stability, and operational scalability.

Technical Observation (on the daily chart):

The 14-day Relative Strength Index (RSI) is currently at 42.61, currently consolidating near mid-levels, with the expectations of consolidation or upward momentum if the USD 25.00-USD 27.00 support holds. In addition, the current price is below both the 50-day Simple Moving Averages (SMAs) and 200-day SMA, which may work as medium to long term resistance levels.

 

As per the above-mentioned price action, recent key business and financial updates, momentum in the stock over the last month, and technical indicators analysis, a ‘Speculative Buy’ rating has been given Lemonade, Inc. (NYSE: LMND) at the closing price of USD 27.30, as of April 22, 2025.

Individuals can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario. 

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

Related Risk: This report may be looked at from a high-risk perspective and a recommendation is provided for a short duration. This report is solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc. 

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is April 22, 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.

 

 

 

 

 

 


Disclaimer-

This report has been issued by Kalkine Limited (Company number 07903332), a private limited company, incorporated in England and Wales ("Kalkine”). Kalkine.co.uk and associated pages are published by Kalkine. Kalkine is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites.  All information represents our views at the date of publication and may change without notice. The information in this report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain non personalized recommendations to invest in securities and other financial products.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall not be held liable for any investment or trading losses you may incur by using the opinions expressed in our reports, publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Please also read our Terms & Conditions for further information. Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this report or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Kalkine Media Limited, an affiliate of Kalkine, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website including entities covered in this report.

Past performance is not a reliable indicator of future performance.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions